{
  "info": {
    "company_name": "Castle Biosciences, Inc.",
    "company_url": "https://www.responsibilityreports.com/Company/castle-biosciences-inc",
    "ticker_name": "CSTL",
    "exchange": "NASDAQ",
    "industry": "Diagnostic Substances",
    "sector": "Healthcare",
    "about_company": "Castle Biosciences (Nasdaq: CSTL) is a commercial-stage dermatologic cancer company focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The Company currently offers tests for patients with cutaneous melanoma (DecisionDx\u00ae-Melanoma, DecisionDx\u00ae-CMSeq; www.SkinMelanoma.com), cutaneous squamous\u2026More",
    "num_employees": "201-500 Employees",
    "location": "Based in Friendswood, Texas"
  },
  "reports": [
    {
      "pdf_url": "https://www.responsibilityreports.com/HostedData/ResponsibilityReports/PDF/NASDAQ_CSTL_2021.pdf",
      "report_name": "NASDAQ_CSTL_2021"
    }
  ]
}